Inhibition of Formation of Calcium Phosphate Deposits on Teeth and Dental Materials: Recent Advances

Abstract

The inorganic composition of dental calculi from teeth and dentures has been characterized by x-ray diffraction, electron microprobe, and infrared absorption spectroscopy. They consist of carbonated hydroxylapatite (CHA), dicalcium phosphate dihydrate (DCPD), octacalcium phosphate (OCP), and magnesium-substituted beta-tricalcium phosphate (6-TCMP). The calculi on denture surfaces are principally CHA. Formulations have been developed to inhibit formation of these calculi in humans. The active inhibitors are pyrophosphate, pyrophosphate plus polymer, and zinc salts. These agents inhibit calculus formation in humans by preventing the formation of hydroxyapatite crystals. The new formulations include multiple-benefits products containing fluoride and antimicrobial and/or desensitizing agents. These provide not only reduction in calculus formation in humans but also reduced plaque, gingivitis, and/or dentinal hypersensitivity. Recent studies have also indicated a relationship between gingival recession and supragingival calculus in the Thai population, and the use of an anticalculus formulation has shown significant improvement in gingival recession in this population.

Keywords

calculus calculus inhibition pyrophosphate copolymer.

Get full access to this article

View all access options for this article.

References

Baelum V. (1987). Pattern of periodontal breakdown in adult Tanzanians . Scand J Dent Res 95:221-228.

Gaffar A. , Moreno EC (1985). Evaluation of 2-phosphonobutane 1,2,4 tricarboxylate as a crystal growth inhibitor in vitro and in vivo. J Dent Res 64:6-10.

Gaffar A. , Polefka T. , Afflitto J. , Esposito A. , Smith S. (1986). In vitro evaluation of pyrophosphate/copolymer/NaF as an anticalculus agent. Compend Contin Ed Dent 8(Suppl):S242-S255.

Gaffar A. , Aoba T. , Afflitto J. , Esposito AD , Moreno EC (1989). Structure-activity relationship between in vitro inhibition of HA crystal growth and in vivo anticalculus effects. In: Recent advances in the study of dental calculus. ten Cate JM, editor. McLean, VA: IRL Press, pp. 155-171.

Gaffar A. , Esposito A. , Afflitto J. (1990). In vitro and in vivo anticalculus effects of a triclosan/copolymer system. Am J Dent 3:S37-S42.

Gaffar A. , Coleman EJ , Olsen S. , Afflitto J. , Rustogi K. (1991). Influence of an anticalculus mouthrinse treatment on the dentition and periodontium in beagle dogs. J Clin Dent 3(Suppl B):B12-B18.

Graf H. , Glasse R. (1977). Morbidity, prevalence and intraoral distribution of hypersensitive teeth (abstract). J Dent Res 56(Spec Iss):A162.

LeGeros RZ (1974). Variations in the crystalline components of human dental calculus: Crystallographic and spectroscopic methods of analyses. J Dent Res 53:45-50. LeGeros RZ (1981). Apatites in biological systems. Prog Cryst Growth Char 4:1-45.

LeGeros RZ (1991). Calcium phosphates in oral biology and medicine . Monogr in Oral Sci. Vol. 15. Myers HM, editor. Basel: S. Karger.

10.

LeGeros RZ , Shannon IL (1979). The crystallizing components of dental calculi: Human vs. dog. J Dent Res 58:2371-2377.

11.

LeGeros RZ , Shirra WP , Miravite MA , LeGeros JP (1975). Amorphous calcium phosphates: Synthetic and biological. Coll. Internationaux CNRS No. 230, "Physico-chimie et Cristallographie des Apatis d'Interet Biologique". pp. 105-115.

12.

LeGeros RZ , Lee D. , Quirolgico G. , Shirra WP , Reich L. (1983). In vitro formation of dicalcium phosphate dihydrate, CaHPO4·2H2O (DCPD). Scan Electron Microsc (Pt 1):407-418.

13.

LeGeros RZ , Kijkowska R. , LeGeros JP (1984). Formation and transformation of octacalcium phosphate, OCP. Scan Electron Microsc 4:1771-1777.

14.

LeGeros RZ , Kijkowska R. , Jia WT , LeGeros JP (1988a). Fluoride/cation interaction in the formation and stability of apatites. J Fluor Chem 41:53-64.

15.

LeGeros RZ , Orly I. , LeGeros JP , Gomez C. , Kazimiroff J. , Tarpley T. , et al. (1988b). Scanning electron microscopy and electron probe microanalyses of the crystalline components of human and animal dental calculi. Scan Microsc 2:345-356.

16.

Mandel ID (1992). Rinses for the control of supragingival calculus formation. Int Dent J 42:270-275.

17.

Mandel I. , Gaffar A. (1986). Calculus revisited. A review. J Clin Periodontol 13:249-257.

18.

Margolis H. , Varughese K. , Moreno EC (1982). Effect of fluoride on crystal growth of calcium apatite in the presence of a salivary inhibitor. Calcif Tissue Int 39:33-40.

19.

Miller S. , Gaffar A. , Sullivan R. , Hen R. , Truong T. , Stranick M. (1994). Evaluation of a new dentifrice for the treatment of sensitive teeth. J Clin Dent 5(Spec Iss):71-79.

20.

Paloheimo L. , Ainamo J. , Niemi ML , Viikinkoski M. (1987). Prevalence of and factors related to gingival recession in Finnish 15 to 20 year old subjects. Community Dent Health 4:425-436.

21.

Schiff T. , Dotson M. , Cohen S. , Devizio W. , McCool J. , Volpe AR (1994). Efficacy of a dentifrice containing potassium nitrate, soluble pyrophosphate, PVM/MA copolymer, and sodium fluoride on dentinal hypersensitivity: A twelve-week clinical study. J Clin Dent 5(Spec Iss):87-92.

22.

Schroeder HE (1969). Formation and inhibition of dental calculus. Berne: Verlag H. Huber, pp. 11-69.

23.

Stephen KW , Saxton CA , Jones CL (1990). Control of gingivitis and calculus by a dentifrice containing zinc salt and triclosan. J Periodont 61:674-679.

24.

Triratana T. , Kraiwaphan P. , Rustogi KN , Lindhe J. , Volpe AR (1991). The effect of an nticalculus dentifrice on calculus formation and gingival recession in Thai children and teenagers. One-year study #1: An anticalculus dentifrice containing 3.3% soluble pyrophosphate and 1.0% of a copolymer. J Clin Dent 3(Suppl B):B26-B30.

25.

Volpe A. , Petrone M. , Davies RM (1993). A review of calculus clinical efficacy studies . J Clin Dent 4:71-81.

26.

Yoneyoma T. , Okamoto H. , Lindhe J. , Socransky SS , Haffajee AD (1988). Probing depth, attachment loss and gingival recession . J Clin Periodont 15:581-591.